As of 28 Aug 2026, Glaxosmithkline Pharmaceuticals Ltd share price is ₹3,068.35. The stock opened at ₹3,068.35 and had closed at ₹3,027.50 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹2,088.00 and a high of ₹3,051.00. In terms of performance, Glaxosmithkline Pharmaceuticals Ltd share price has increased by 15.75% over the past six months and has increased by 10.24% over the last year.
GLAXO Charts
Glaxosmithkline Pharmaceuticals Ltd Overview
About GLAXO
GlaxoSmithKline Pharmaceuticals is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals.
Glaxosmithkline Pharmaceuticals Ltd Historical Performance
Glaxosmithkline Pharmaceuticals Ltd Fundamental Analysis
Glaxosmithkline Pharmaceuticals Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 986.05 | 1,024.86 | 1,054.41 | 1,004.90 | 848.59 |
| EBITDA | 354.79 | 382.90 | 399.40 | 368.59 | 294.51 |
| Net Profit | 253.33 | 274.94 | 277.18 | 255.00 | 204.70 |
| EPS | 14.95 | 16.23 | 16.36 | 14.92 | 12.08 |
Glaxosmithkline Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 73.94 |
| MACD | 128.25 |
| 20-Day SMA | 2,746.65 |
Glaxosmithkline Pharmaceuticals Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Glaxosmithkline Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Glaxosmithkline Pharmaceuticals Ltd today is ₹3,068.35 on NSE and ₹3,068.35 on BSE.
- The 52-week high of Glaxosmithkline Pharmaceuticals Ltd is ₹3,051.00, while the 52-week low is ₹2,088.00.
- The current market capitalisation of Glaxosmithkline Pharmaceuticals Ltd is approximately ₹51,980 crore.
- The P/E (Price-to-Earnings) ratio of Glaxosmithkline Pharmaceuticals Ltd is 41.19. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Glaxosmithkline Pharmaceuticals Ltd is 24.63. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Glaxosmithkline Pharmaceuticals Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Glaxosmithkline Pharmaceuticals Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Glaxosmithkline Pharmaceuticals Ltd has delivered a return of approximately 118.12%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Glaxosmithkline Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 75.00% promoters, -0.08% FIIs, 7.80% DIIs, and 10.21% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
